QQQ   355.99 (-1.46%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
QQQ   355.99 (-1.46%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
QQQ   355.99 (-1.46%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
QQQ   355.99 (-1.46%)
AAPL   172.56 (-0.68%)
MSFT   313.82 (-2.48%)
META   301.38 (-1.77%)
GOOGL   133.25 (-0.69%)
AMZN   125.49 (-3.07%)
TSLA   248.35 (-1.29%)
NVDA   439.12 (-1.94%)
NIO   8.72 (-0.80%)
BABA   84.82 (-1.98%)
AMD   101.04 (-2.16%)
T   14.64 (-0.20%)
F   12.11 (-1.62%)
MU   68.59 (+0.93%)
CGC   0.70 (-5.36%)
GE   107.79 (-0.92%)
DIS   80.11 (-1.91%)
AMC   8.12 (-0.37%)
PFE   33.95 (+0.03%)
PYPL   57.81 (-1.28%)
NFLX   379.03 (-0.34%)
NASDAQ:DRTS

Alpha Tau Medical (DRTS) Stock Forecast, Price & News

$3.47
-0.12 (-3.34%)
(As of 11:31 AM ET)
Compare
Today's Range
$3.47
$3.60
50-Day Range
$2.95
$3.97
52-Week Range
$2.75
$5.95
Volume
15,825 shs
Average Volume
62,290 shs
Market Capitalization
$240.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.67

Alpha Tau Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
322.7% Upside
$14.67 Price Target
Short Interest
Healthy
0.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Alpha Tau Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.50) to ($0.61) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Medical Sector

280th out of 976 stocks

Surgical & Medical Instruments Industry

40th out of 99 stocks


DRTS stock logo

About Alpha Tau Medical (NASDAQ:DRTS) Stock

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

DRTS Price History

DRTS Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Recap: Alpha Tau Medical Q1 Earnings
Alpha Tau Medical Ltd (DRTS) Receives a Buy from H.C. Wainwright
DRTS Alpha Tau Medical Ltd.
See More Headlines
Receive DRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpha Tau Medical and its competitors with MarketBeat's FREE daily newsletter.

DRTS Company Calendar

Last Earnings
8/28/2023
Today
10/03/2023
Next Earnings (Estimated)
11/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DRTS
Fax
N/A
Employees
94
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.67
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+308.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-33,760,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.58 per share

Miscellaneous

Free Float
41,971,000
Market Cap
$249.04 million
Optionable
Not Optionable
Beta
0.93
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Uzi Sofer (Age 53)
    CEO & Chairman
    Comp: $1.58M
  • Mr. Raphi Levy (Age 38)
    Chief Financial Officer
    Comp: $1.24M
  • Mr. Amnon Gat (Age 48)
    Chief Operations Officer
    Comp: $497k
  • Mr. Ronen Segal (Age 50)
    Chief Technology Officer
    Comp: $380k
  • Dr. Robert B. Den M.D. (Age 44)
    Chief Medical Officer & Member of Scientific Advisory Board
    Comp: $565k
  • Prof. Yona Keisari (Age 76)
    Chief Scientific Officer & Member of Scientific Advisory board
  • Ms. Rebecca Becker
    VP of legal
  • Mr. Peter M. Melnyk (Age 61)
    Chief Commercial Officer
  • Prof. Itzhak Kelson (Age 83)
    Chief Physics Officer & Member of Scientific Advisory Board
  • Ms. Yael Zeiger (Age 40)
    Corp. Controller













DRTS Stock - Frequently Asked Questions

Should I buy or sell Alpha Tau Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alpha Tau Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DRTS shares.
View DRTS analyst ratings
or view top-rated stocks.

What is Alpha Tau Medical's stock price forecast for 2023?

3 analysts have issued 1 year price objectives for Alpha Tau Medical's shares. Their DRTS share price forecasts range from $9.00 to $23.00. On average, they anticipate the company's share price to reach $14.67 in the next twelve months. This suggests a possible upside of 308.5% from the stock's current price.
View analysts price targets for DRTS
or view top-rated stocks among Wall Street analysts.

How have DRTS shares performed in 2023?

Alpha Tau Medical's stock was trading at $3.18 at the beginning of 2023. Since then, DRTS stock has increased by 12.9% and is now trading at $3.59.
View the best growth stocks for 2023 here
.

Are investors shorting Alpha Tau Medical?

Alpha Tau Medical saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 122,200 shares, a decline of 22.9% from the August 31st total of 158,500 shares. Based on an average daily volume of 70,200 shares, the short-interest ratio is currently 1.7 days. Currently, 0.3% of the company's shares are short sold.
View Alpha Tau Medical's Short Interest
.

When is Alpha Tau Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 28th 2023.
View our DRTS earnings forecast
.

How were Alpha Tau Medical's earnings last quarter?

Alpha Tau Medical Ltd. (NASDAQ:DRTS) posted its quarterly earnings data on Monday, August, 28th. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.13).

What is Alpha Tau Medical's stock symbol?

Alpha Tau Medical trades on the NASDAQ under the ticker symbol "DRTS."

How do I buy shares of Alpha Tau Medical?

Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alpha Tau Medical's stock price today?

One share of DRTS stock can currently be purchased for approximately $3.59.

How much money does Alpha Tau Medical make?

Alpha Tau Medical (NASDAQ:DRTS) has a market capitalization of $249.04 million. The company earns $-33,760,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.

How can I contact Alpha Tau Medical?

Alpha Tau Medical's mailing address is 301 N. MARKET STREET STE 1414, WILMINGTON DE, 19801. The official website for the company is healthcarecapitalcorp.com. The company can be reached via phone at 972-3577-4115 or via email at ir@alphatau.com.

This page (NASDAQ:DRTS) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -